Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001149200 on April 11, 2000

J. Biol. Chem., Vol. 275, Issue 27, 20382-20390, July 7, 2000
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/27/20382    most recent
M001149200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, P.
Right arrow Articles by Rapp, U. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, P.
Right arrow Articles by Rapp, U. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Transactivation of Naturally Occurring HIV-1 Long Terminal Repeats by the JNK Signaling Pathway
THE MOST FREQUENT NATURALLY OCCURRING LENGTH POLYMORPHISM SEQUENCE INTRODUCES A NOVEL BINDING SITE FOR AP-1 FACTORS*

Peifeng ChenDagger §, Egbert FloryDagger §, Andris Avots||, Bruce W. M. JordanDagger , Frank Kirchhoff**, Stephan LudwigDagger , and Ulf R. RappDagger

From the Dagger  Institut für Medizinische Strahlenkunde und Zellforschung, Universität Würzburg, Versbacher Strasse 5, D-97078 Würzburg, Germany, the ** Institut für Klinische und Molekulare Virologie, Universität Erlangen, Schlobeta garten 4, D-91054 Erlangen, Germany, and the || Institut für Pathologie, Universität Würzburg, Joseph-Schneider-Strasse 2, D-97078 Würzburg, Germany

To study the role of MAPK cascades in the regulation of naturally occurring human immunodeficiency virus type 1 long terminal repeats (HIV-1 LTRs), we analyzed several HIV-1 LTRs from patients at different stages of disease progression. One of these naturally occurring HIV-1 LTRs contains an insertion termed the most frequent naturally occurring length polymorphism (MFNLP) and exhibited high inducibility upon T cell activation. We found that the protein kinase mixed lineage kinase 3/src-homology 3 domain-containing proline-rich kinase, a specific activator of the stress-activated protein kinase (SAPK)/JNK signaling pathway in T lymphocytes, induces high transcriptional activation of this promoter. Promoter inducibility is inhibited by the SAPK/JNK inhibitor, the JNK binding domain of the JNK interacting protein 1, and Tam-67 (N-terminal deletion mutant of c-Jun). In electrophoretic mobility shift assay, several protein complexes were found to bind to the MFNLP sequence in T cells. We identified AP-1 factors c-Fos and JunB as MFNLP-binding proteins, whose binding is abolished by introducing point mutations in the 3'-half of the MFNLP sequence. Introduction of these point mutations into the MFNLP containing HIV-1 LTR reduced src-homology 3 domain-containing proline-rich kinase -mediated transactivation. These data indicate that the AP-1-like binding site in the MFNLP sequence gives rise to a higher inducibility of natural HIV-LTRs by the SAPK/JNK signaling pathway.


* This work was supported by the Deutsche Forschungsgemeinshaft Grants SFB165 and SFB172 (to U. R. R.) and Lu477/4-1 (to S. L.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Contributed equally to this work.

To whom correspondence should be addressed: Paul-Ehrlich Institut, Abteilung Medizinische Biotechnologie, Paul-Ehrlich Strasse 95, D-63225 Langen, Germany. Tel.: 49-6103-775206; Fax: 49-6103-771255; E-mail: floeg@pei.de.


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
C. Rizzi, M. P. Crippa, R. E. Jeeninga, B. Berkhout, F. Blasi, G. Poli, and M. Alfano
Pertussis Toxin B-Oligomer Suppresses IL-6 Induced HIV-1 and Chemokine Expression in Chronically Infected U1 Cells via Inhibition of Activator Protein 1
J. Immunol., January 15, 2006; 176(2): 999 - 1006.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
N. E. Faulkner, B. R. Lane, P. J. Bock, and D. M. Markovitz
Protein Phosphatase 2A Enhances Activation of Human Immunodeficiency Virus Type 1 by Phorbol Myristate Acetate
J. Virol., February 1, 2003; 77(3): 2276 - 2281.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. K. Barr, T. S. Kendrick, and M. A. Bogoyevitch
Identification of the Critical Features of a Small Peptide Inhibitor of JNK Activity
J. Biol. Chem., March 22, 2002; 277(13): 10987 - 10997.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement